| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 9e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |